Showing the single result
-
Add to cartFeature Specification Details Active Ingredient Tirzepatide (Dual GIP / GLP-1 Receptor Agonist) Bundle Contents 1 x 2.5mg KwikPen (4 doses) + 1 x 5mg KwikPen (4 doses) Total Duration 8 Weeks of continuous medical treatment Administration Route Subcutaneous injection (Once weekly) Storage Protocols Refrigerate at 2°C – 8°C; Unrefrigerated stable up to 30 days below 30°C Target Indications Chronic weight management, metabolic support, and obesity care